Curcumin alleviates matrix metalloproteinase-3 and -9 activities during eradication of Helicobacter pylori infection in cultured cells and mice

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Kundu, Parag ^a,c   De, Ronita ^b   Pal, Ipsita ^a   Mukhopadhyay, Asish K ^b   Saha, Dhira Rani ^b   Swarnakar, Snehasikta ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CURCUMIN; GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OMEPRAZOLE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STROMELYSIN; TINIDAZOLE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR AP 1; AUTACOID; ENZYME INHIBITOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION CONTROL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; INFLAMMATION; METABOLISM; PATHOLOGY; STOMACH;

HELICOBACTER PYLORI; MUS;

ANIMALS; CELLS, CULTURED; CURCUMIN; DOWN-REGULATION; ENZYME INHIBITORS; HELICOBACTER INFECTIONS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MICE; STOMACH;

EID: 79551553844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016306     Document Type: Article

References (54)

1. Moller H, Heseltine E, Vainio H (1995) Working group report on schistosomes, liver flukes and Helicobacter pylori. Int J Cancer 60: 587-589.
2. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, et al. (1997) The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388: 539-547.
3. Blaser MJ (1998) Helicobacter pylori and gastric diseases. Bmj 316: 1507-1510.
4. Bytzer P, O'Morain C (2005) Treatment of Helicobacter pylori. Helicobacter 10: 40-46.
5. Cameron EA, Powell KU, Baldwin L, Jones P, Bell GD, et al. (2004) Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001. J Med Microbiol 53: 535-538.
6. Bergin PJ, Anders E, Sicheng W, Erik J, Jennie A, et al. (2004) Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis. Helicobacter 9: 201-210.
7. Gooz M, Shaker M, Gooz P, Smolka AJ (2003) Interleukin 1beta induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection. Gut 52: 1250-1256.
8. Mori N, Sato H, Hayashibara T, Senba M, Geleziunas R, et al. (2003) Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor kappaB. Gastroenterology 124: 983-992.
9. Swarnakar S, Ganguly K, Kundu P, Banerjee A, Maity P, et al. (2005) Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem 280: 9409-9415.
10. Kundu P, Mukhopadhyay AK, Patra R, Banerjee A, Berg DE, et al. (2006) Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J Biol Chem 281: 34651-34662.
11. Pillinger MH, Marjanovic N, Kim SY, Scher JU, Izmirly P, et al. (2005) Matrix metalloproteinase secretion by gastric epithelial cells is regulated by E prostaglandins and MAPKs. J Biol Chem 280: 9973-9979.
12. Parks WC, Mecham RP (1998) Matrix Metalloproteinases. New York: Academic Press.
13. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
14. Ganguly K, Sharma AV, Reiter RJ, Swarnakar S (2010) Melatonin promotes angiogenesis during protection and healing of indomethacin-induced gastric ulcer: role of matrix metaloproteinase-2. J 49: 130-140.
15. Wroblewski LE, Noble PJ, Pagliocca A, Pritchard DM, Hart CA, et al. (2003) Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration. J Cell Sci 116: 3017-3026.
16. Clutterbuck AL, Asplin KE, Harris P, Allaway D, Mobasheri A (2009) Targeting matrix metalloproteinases in inflammatory conditions. Curr Drug Targets 10: 1245-1254.
17. Qureshi S, Shah AH, Ageel AM (1992) Toxicity studies on Alpinia galanga and Curcuma longa. Planta Med 58: 124-127.
18. Foryst-Ludwig A, Neumann M, Schneider-Brachert W, Naumann M (2004) Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells. Biochem Biophys Res Commun 316: 1065-1072.
19. Han C, Wang L, Yu K, Chen L, Hu L, et al. (2006) Biochemical characterization and inhibitor discovery of shikimate dehydrogenase from Helicobacter pylori. Febs J 273: 4682-4692.
20. Shishodia S, Chaturvedi MM, Aggarwal BB (2007) Role of curcumin in cancer therapy. Curr Probl Cancer 31: 243-305.
21. Mahady GB, Pendland SL, Yun G, Lu ZZ (2002) Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res 22: 4179-4181.
22. Munzenmaier A, Lange C, Glocker E, Covacci A, Moran A, et al. (1997) A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. J Immunol 159: 6140-6147.
23. De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, et al. (2009) Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 53: 1592-1597.
24. Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, et al. (2007) Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 13: 470-476.
25. Meyer-ter-Vehn T, Covacci A, Kist M, Pahl HL (2000) Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem 275: 16064-16072.
26. Francois M, Richette P, Tsagris L, Raymondjean M, Fulchignoni-Lataud MC, et al. (2004) Peroxisome proliferator-activated receptor-gamma down-regulates chondrocyte matrix metalloproteinase-1 via a novel composite element. J Biol Chem 279: 28411-28418.
27. Lee KJ, Kim HA, Kim PH, Lee HS, Ma KR, et al. (2004) Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-g. Exp Mol Med 36: 534-544.
28. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82.
29. Overall CM, Kleifeld O (2006) Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6: 227-239.
30. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, et al. (2000) Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289: 1202-1206.
31. Rodriguez D, Morrison CJ, Overall CM (1803) Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim Biophys Acta 2010: 39-54.
32. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, et al. (2003) Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300: 1430-1434.
33. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, et al. (2004) Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5: 1166-1174.
34. Kositchaiwat C, Kositchaiwat S, Havanondha J (1993) Curcuma longa Linn. in the treatment of gastric ulcer comparison to liquid antacid: a controlled clinical trial. J Med Assoc Thai 76: 601-605.
35. Nam KT, Oh SY, Ahn B, Kim YB, Jang DD, et al. (2004) Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase. Gut 53: 1250-1255.
36. Shimada T, Terano A (1998) Chemokine expression in Helicobacter pyloriinfected gastric mucosa. J Gastroenterol 33: 613-617.
37. Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, et al. (2003) Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clin Cancer Res 9: 3167-3175.
38. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
39. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, et al. (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NFkappa B activation. Mutat Res 480-481: 243-268.
40. Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, et al. (2002) Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 95: 1902-1910.
41. Ridnour LA, Windhausen AN, Isenberg JS, Yeung N, Thomas DD, et al. (2007) Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclasedependent and -independent pathways. Proc Natl Acad Sci U S A 104: 16898-16903.
42. Keates S, Hitti YS, Upton M, Kelly CP (1997) Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology 113: 1099-1109.
43. Wu CY, Wang CJ, Tseng CC, Chen HP, Wu MS, et al. (2005) Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2- mediated pathway. World J Gastroenterol 11: 3197-3203.
44. Kim SY, Jung SH, Kim HS (2005) Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. Biochem Biophys Res Commun 337: 510-516.
45. Saja K, Babu MS, Karunagaran D, Sudhakaran PR (2007) Anti-inflammatory effect of curcumin involves downregulation of MMP-9 in blood mononuclear cells. Int Immunopharmacol 7: 1659-1667.
46. Shakibaei M, John T, Schulze-Tanzil G, Lehmann I, Mobasheri A (2007) Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol 73: 1434-1445.
47. Fahmi H, Di Battista JA, Pelletier JP, Mineau F, Ranger P, et al. (2001) Peroxisome proliferators-activated receptor gamma activators inhibit interleukin- 1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis Rheum 44: 595-607.
48. Konturek PC, Kania J, Konturek JW, Nikiforuk A, Konturek SJ, et al. (2003) H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired apoptosis in gastric carcinogenesis. Med Sci Monit 9: SR53-66.
49. Zhang M, Deng C, Zheng J, Xia J, Sheng D (2006) Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. Int Immunopharmacol 6: 1233-1242.
50. Ghosh MN (2005) Fundamentals of pharmacology. Kolkata: Hilton.
51. Chattopadhyay S, Datta S, Chowdhury A, Chowdhury S, Mukhopadhyay AK, et al. (2002) Virulence genes in Helicobacter pylori strains from West Bengal residents with overt H. pylori-associated disease and healthy volunteers. J Clin Microbiol 40: 2622-2625.
52. Sambrook J, Russell DW (2001) Molecular cloning a laboratory manual. harbor Coldspring harbor, New York: Cold spring harbor laboratory press.
53. Ganguly K, Kundu P, Banerjee A, Reiter RJ, Swarnakar S (2006) Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin- induced acute gastric ulceration is blocked by melatonin and other antioxidants. Free Radic Biol Med 41: 911-925.
54. Kasperczyk H, La Ferla-Bruhl K, Westhoff MA, Behrend L, Zwacka RM, et al. (2005) Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy. Oncogene 24: 6945-6956.